Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006

AudioMedica News
AudioMedica News
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
Loading
/
Judith Hochman
Judith Hochman
Timothy Gardner
Timothy Gardner
Girish Mood
Girish Mood
Marc Cohen
Marc Cohen

Late Opening of Total Occlusion: No Benefit from PCI for Patients with STEMI

REFERENCE: LBCT II News Conference November 14th 2006
JUDITH HOCHMAN, New York University School of Medicine
COMMENT: TIMOTHY GARDNER, Christiana Care, Delaware
Opening a patient’s occluded artery between 3-28 days after a myocardial infarction does not improve outcome. Judith Hochman presented surprising data from the Occluded Artery Trial (OAT) that showed the addition of PCI to optimal medical treatment was no better than medical therapy alone. Sarah Maxwell heard more from her at the American Heart Association meeting in Chicago.

Aggressive Statins: Big Benefit in Elective Angioplasty

REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract 3074: Poster C239 Tuesday
GIRISH MOOD, Cleveland Clinic, Ohio
Aggressive statin therapy is recommended for patients receiving elective percutaneous intervention according to researchers at the Cleveland Clinic. At the AHA Sessions in Chicago Girish Mood told Peter Goodwin about the meta analysis they’ve done which endorses intense use of statins.

Bleeding Risk Score in Patients Having Elective Angioplasty

American Heart Association Scientific Sessions 2006 November 12-15th Chicago, Illinois. Abstract: 3073: Poster C 238, Tuesday
MARC COHEN, Mt Sinai School of Medicine, Newark NJ
A simple score to predict bleeding risk among patients having elective angioplasty has come out of the international STEEPLE Trial looking at 3500 patients. Marc Cohen told Peter Goodwin at the AHA Sessions about the three factors which have emerged as risks: female gender, the choice of heparin, and the use of glycoprotein 2b3a inhibition.

[audio:https://www.audiomedica.com/podcasting/aha/061115AHA4thPodcast.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality